By Matt Grossman

 

Biogen Inc. Thursday raised its full-year revenue forecast Thursday, but held constant its earnings outlook.

The Cambridge, Mass.-based drug maker said it now expects revenue of $10.65 billion to $10.85 billion in 2021. It had previously forecast revenue of $10.45 to $10.75 billion.

Biogen held steady its adjusted earnings forecast, targeting earnings of $17.50 to $19 a share.

Analysts surveyed by FactSet had been forecasting adjusted earnings of $18.50 a share on sales of $10.61 billion.

 

Write to Matt Grossman at matt.grossman@wsj.com

 

(END) Dow Jones Newswires

July 22, 2021 08:01 ET (12:01 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Biogen (NASDAQ:BIIB)
Gráfica de Acción Histórica
De Jul 2021 a Ago 2021 Haga Click aquí para más Gráficas Biogen.
Biogen (NASDAQ:BIIB)
Gráfica de Acción Histórica
De Ago 2020 a Ago 2021 Haga Click aquí para más Gráficas Biogen.